Overview

Phase 1a Study in Healthy Smokers to Investigate the Effect With MMI-0100 on Airway Inflammation in Induced Sputum After Challenge With Inhaled Lipopolysaccharide

Status:
Unknown status
Trial end date:
2017-06-01
Target enrollment:
Participant gender:
Summary
A Phase 1a, randomized, placebo controlled, two-way crossover study is to determine the effect of inhaled MMI-0100 compared to placebo following LPS challenge on inflammatory markers.
Phase:
Phase 1
Details
Lead Sponsor:
Moerae Matrix, Inc.